Entrectinib versus crizotinib in Asian patients with ROS1-positive non-small cell lung cancer: A matching-adjusted indirect comparison. Yu Y, Fan Y, Dong X, Li J, et al. Lung Cancer 2024;198:108018.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu Y, Fan Y, Dong X, Li J, et al. Entrectinib versus crizotinib in Asian patients with ROS1-positive non-small cell lung cancer: A matching-adjusted indirect comparison. Lung Cancer 2024;198:108018.
PMID: 39549678